The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Glucosamine therapy for treating osteoarthritis
Open accessAbstract
BACKGROUND: Osteoarthritis (OA) is the most common form of arthritis, and it is often associated with significant disability and an impaired quality of life. OBJECTIVES: To review all randomized controlled trials (RCTs) evaluating the effectiveness and toxicity of glucosamine in OA. SEARCH STRATEGY: We searched MEDLINE, PREMEDLINE, EMBASE, AMED, ACP Journal Club, DARE, CDSR, and the CCTR. We also wrote letters to content experts, and hand searched reference lists of identified RCTs and pertinent review articles. All searches were updated in January 2005. SELECTION CRITERIA: Relevant studies met the following criteria: 1) RCTs evaluating the effectiveness and safety of glucosamine in OA, 2) Both placebo controlled and comparative studies were eligible, 3) Both single blinded and double blinded studies were eligible. DATA COLLECTION AND ANALYSIS: Data abstraction was performed independently by two investigators and the results were compared for degree of agreement. Gotzsche's method and a validated tool (Jadad 1996) were used to score the quality of the RCTs. Continuous outcome measures were pooled using standardized mean differences (SMD) as the measure of effect size. Dichotomous outcome measures were pooled using relative risk ratios (RR). MAIN RESULTS: Analysis restricted to eight studies with adequate allocation concealment failed to show benefit of glucosamine for pain and WOMAC function. Collectively, the 20 analyzed RCTs found glucosamine favoured placebo with a 28% (change from baseline) improvement in pain (SMD -0.61, 95% CI -0.95, -0.28) and a 21% (change from baseline) improvement in function using the Lequesne index (SMD -0.51 95% CI -0.96, -0.05). However, the results are not uniformly positive, and the reasons for this remain unexplained. WOMAC pain, function and stiffness outcomes did not reach statistical significance. In the 10 RCTs in which the Rotta preparation of glucosamine was compared to placebo, glucosamine was found to be superior for pain (SMD -1.31, 95% CI -1.99, -0.64) and function using the Lequesne index (SMD -0.51, 95% CI -0.96, -0.05). Pooled results for pain (SMD -0.15, 95% CI -0.35, 0.05) and function using the WOMAC index (SMD 0.03, 95% CI -0.18, 0.25) in those RCTs in which a non-Rotta preparation of glucosamine was compared to placebo did not reach statistical significance. In the four RCTs in which the Rotta preparation of glucosamine was compared to an NSAID, glucosamine was superior in two, and equivalent in two. Two RCTs using the Rotta preparation showed that glucosamine was able to slow radiological progression of OA of the knee over a three year period (SMD 0.24, 95% CI 0.04, 0.43). Glucosamine was as safe as placebo in terms of the number of subjects reporting adverse reactions (RR=0.97, 95% CI, 0.88, 1.08). AUTHORS' CONCLUSIONS: This update includes 20 studies with 2570 patients. Pooled results from studies using a non-Rotta preparation or adequate allocation concealment failed to show benefit in pain and WOMAC function while those studies evaluating the Rotta preparation show that glucosamine was superior to placebo in the treatment of pain and functional impairment resulting from symptomatic OA. WOMAC outcomes of pain, stiffness and function did not show a superiority of glucosamine over placebo for both Rotta and non-Rotta preparations of glucosamine. Glucosamine was as safe as placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Celecoxib for rheumatoid arthritis
Garner, S. E., Fidan, D., Frankish, R. R., Judd, M., Shea, B., Towheed, T., Tugwell, P., & Wells, G. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003831 · Cited by 67
Self-citationRetractedAssessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
Felson, D. T., Lawrence, R. C., Dieppe, P. A., Hirsch, R., Helmick, C. G., Jordan, J. M., Kington, R. S., Lane, N. E., Nevitt, M. C., Zhang, Y., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00016 · Cited by 2,519
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052771 · Cited by 1,329
Gabriel, S. E., Jaakkimainen, L., & Bombardier, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-10-787 · Cited by 1,237
Reginster, J. Y., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyere, O., Giacovelli, G., Henrotin, Y., Dacre, J. E., & Gossett, C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03610-2 · Cited by 1,234
Guidelines for the medical management of osteoarthritis
Hochberg, M. C., Altman, R. D., Brandt, K. D., Clark, B. M., Dieppe, P. A., Griffin, M. R., Moskowitz, R. W., & Schnitzer, T. J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381103 · Cited by 968
Self-citationMeta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis
Petitti, D. B. (1999) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195133646.001.0001 · Cited by 925
McAlindon, T. E., LaValley, M. P., Gulin, J. P., & Felson, D. T. (2000) · JAMA · doi:10.1001/jama.283.11.1469 · Cited by 849
Griffin, M. R., Piper, J. M., Daugherty, J. R., Snowden, M., & Ray, W. A. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-4-257 · Cited by 758
Bellamy, N., Kirwan, J., Boers, M., Brooks, P., Strand, V., Tugwell, P., Altman, R. D., Brandt, K. D., Dougados, M., & Lequesne, M. G. (1997) · PubMed · Cited by 745
Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., & Rovati, L. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2113 · Cited by 683
Guidelines for the medical management of osteoarthritis
Hochberg, M. C., Altman, R. D., Brandt, K. D., Clark, B. M., Dieppe, P. A., Griffin, M. R., Moskowitz, R. W., & Schnitzer, T. J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381104 · Cited by 676
Self-citationCreamer, P., & Hochberg, M. C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07226-7 · Cited by 394
Self-citationGlucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
Largo, R., Alvarez-Soria, M. A., Dı́ez-Ortego, I., Calvo, E., Sánchez-Pernaute, O., Egido, J., & Herrero-Beaumont, G. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00028-1 · Cited by 386
Richy, F., Bruyere, O., Ethgen, O., Cucherat, M., Henrotin, Y., & Reginster, J.-Y. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1514 · Cited by 368
Gøtzsche, P. C. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90017-2 · Cited by 339
Anderson, J. W., Nicolosi, R. J., & Borzelleca, J. F. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.11.006 · Cited by 311
Monographs in Epidemiology and Biostatistics: Methods in Observational Epidemiology
Kelsey, J. L., Whittemore, A. S., Evans, A. S., & Thompson, W. D. (1996) · doi:10.1093/oso/9780195083774.001.0001 · Cited by 311
Chronic Disease Epidemiology and Control
Remington, P. L., Brownson, R. C., & Wegner, M. V. (2010) · doi:10.2105/9780875531922 · Cited by 310
Herrero‐Beaumont, G., Ivorra, J. A. R., del Carmen Trabado, M., Blanco, F. J., Benito, P., Martín‐Mola, E., Paulino, J., Marenco, J. L., Porto, A., Laffon, A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22371 · Cited by 287
Published Trials of Nonmedicinal and Noninvasive Therapies for Hip and Knee Osteoarthritis
Puett, D. W., & Griffin, M. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-2-199407150-00010 · Cited by 253
EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON THE COURSE OF OSTEOARTHRITIS
Rashad, S., Hemingway, A., Rainsford, K., Revell, P., Low, F., & Walker, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90651-x · Cited by 238
Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee
Müller-Faßbender, H., Bach, G. L., Haase, W., et al. (1994) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80007-x · Cited by 216
NUTRACEUTICALS AS THERAPEUTIC AGENTS IN OSTEOARTHRITIS
Deal, C. L., & Moskowitz, R. W. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70074-0 · Cited by 209
TREATMENT OF CARCINOMA OF THE RECTOSIGMOID REGION
(1947) · The Lancet · doi:10.1016/s0140-6736(47)90559-x · Cited by 202
Glucosamine for pain in osteoarthritis: Why do trial results differ?
Vlad, S. C., LaValley, M. P., McAlindon, T. E., & Felson, D. T. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22728 · Cited by 197
N -Acetylglucosamine Prevents IL-1β-Mediated Activation of Human Chondrocytes
Shikhman, A. R., Kuhn, K., Alaaeddine, N., & Lotz, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5155 · Cited by 194
Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee.
Houpt, J. B., McMillan, R., Wein, C., & Paget-Dellio, S. D. (1999) · PubMed · Cited by 184
Self-citationPersiani, S., Roda, E., Rovati, L. C., Locatelli, M., Giacovelli, G., & Roda, A. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.07.009 · Cited by 179
Hughes, R., & Carr, A. (2002) · Rheumatology · doi:10.1093/rheumatology/41.3.279 · Cited by 165
The double-edged sword of COX-2 selective NSAIDs.
Wright, J. M. (2002) · Europe PMC (PubMed Central) · Cited by 160
McAlindon, T., Formica, M., LaValley, M., Lehmer, M., & Kabbara, K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.023 · Cited by 158
Effects of glucosamine infusion on insulin secretion and insulin action in humans.
Monauni, T., Zenti, M. G., Cretti, A., Daniels, M. C., Targher, G., Caruso, B., Caputo, M., McClain, D. A., Prato, S. D., Giaccari, A., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.6.926 · Cited by 156
Pujalte, J. M., Llavore, E. P., & Ylescupidez, F. R. (1980) · Current Medical Research and Opinion · doi:10.1185/03007998009112036 · Cited by 150
Vaz, A. L. (1982) · Current Medical Research and Opinion · doi:10.1185/03007998209112375 · Cited by 149
Rofecoxib (Vioxx) voluntarily withdrawn from market
Sibbald, B. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041606 · Cited by 141
Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee
Rindone, J. P., Hiller, D., Collacott, E., Nordhaugen, N., & Arriola, G. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.172.2.91 · Cited by 139
Towheed, T., & HOCHBERG, M. (1997) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(97)80043-1 · Cited by 139
Self-citationCibere, J., Kopec, J. A., Thorne, A., Singer, J., Canvin, J., Robinson, D., Pope, J. E., Hong, P., Grant, E., & Esdaile, J. M. (2004) · Arthritis Care & Research · doi:10.1002/art.20697 · Cited by 138
Laverty, S., Sandy, J. D., Céleste, C., Vachon, P., Marier, J., & Plaas, A. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20762 · Cited by 135
Glucosamine sulphate for the management of arthrosis: A controlled clinical investigation
Crolle, G., & D'este, E. (1980) · Current Medical Research and Opinion · doi:10.1185/03007998009112035 · Cited by 135
Drovanti, A., Aa, B., & Rovati, A. L. (1980) · PubMed · Cited by 129
Effect of Glucosamine Sulfate on Hip Osteoarthritis
Rozendaal, R. M., Koes, B. W., van Osch, G. J. V. M., Uitterlinden, E. J., Garling, E. H., Willemsen, S. P., Ginai, A. Z., Verhaar, J. A. N., Weinans, H., & Bierma‐Zeinstra, S. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00005 · Cited by 128
Costs and outcomes in rheumatoid arthritis and osteoarthritis
Liang, M. H., Larson, M. G., Thompson, M., Eaton, H. M., McNamara, E. A., Katz, R. S., & Taylor, J. E. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270507 · Cited by 126
Absorption, Distribution, Metabolism and Excretion of Glucosamine Sulfate
Setnikar, I., & Rovati, L. C. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300105 · Cited by 126
Active ingredient consistency of commercially available glucosamine sulfate products.
RUSSELL, A. S., Aghazadeh‐Habashi, A., & Jamali, F. (2002) · PubMed · Cited by 104
Statistical Methods for Meta-Analysi's
Stock, W. A. (1987) · Applied Psychological Measurement · doi:10.1177/014662168701100108 · Cited by 97
Biggee, B. A., Blinn, C. M., McAlindon, T. E., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036368 · Cited by 96
Reichelt, A. J., Förster, K. K., Fischer, M., Rovati, L. C., & Setnikar, I. (1994) · PubMed · Cited by 96
Glucosamine sulphate: a controlled clinical investigation in arthrosis.
D'Ambrosio, E., Casa, B., Bompani, R., Scali, G., & Scali, M. (1981) · PubMed · Cited by 93
Adebowale, A. O., Cox, D. S., Liang, Z., & Eddington, N. D. (2000) · Cited by 91
Barclay, T. S., Tsourounis, C., & McCart, G. M. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17235 · Cited by 91
The effect of glucosamine supplementation on people experiencing regular knee pain
Braham, R., Dawson, B., & Goodman, C. (2003) · British Journal of Sports Medicine · doi:10.1136/bjsm.37.1.45 · Cited by 89
Glucosamine Sulfate for Osteoarthritis
da Camara, C. C., & Dowless, G. V. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17214 · Cited by 87
In-vitro evaluation of drugs proposed as chondroprotective agents.
Bassleer, C., Henrotin, Y. E., & Franchimont, P. (1992) · PubMed · Cited by 85
Tapadinhas, M. J., Rivera, I. L., & Bignamini, A. (1982) · PubMed · Cited by 80
Muniyappa, R., Karne, R. J., Hall, G., Crandon, S. K., Bronstein, J. A., Ver, M. R., Hortin, G. L., & Quon, M. J. (2006) · Diabetes · doi:10.2337/db06-0714 · Cited by 70
y Plana, R. R. V., Bizzarri, D., & Rovati, A. L. (1978) · Pharmacological Research Communications · doi:10.1016/s0031-6989(78)80054-x · Cited by 69
The neglect of glucosamine as a treatment for osteoarthritis — A personal perspective
McCarty, M. F. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90007-8 · Cited by 65
Management of Osteoarthritis in Older Adults
Creamer, P., Flores, R. H., & Hochberg, M. C. (1998) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30100-9 · Cited by 61
Self-citationTannis, A., Barban, J., & Conquer, J. A. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.03.001 · Cited by 60
Oral Glucosamine in Doses Used to Treat Osteoarthritis Worsens Insulin Resistance
Pham, T., Cornea, A., Jenkins, A. J., Blick, K. E., & Scofield, R. H. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318065bdbe · Cited by 58
Towheed, T., & Anastassiades, T. (2000) · JAMA · doi:10.1001/jama.283.11.1483 · Cited by 58
Self-citationMroz, P. J., & Silbert, J. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20609 · Cited by 53
Biggee, B. A., Blinn, C. M., Nuite, M., Silbert, J. E., & McAlindon, T. E. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058222 · Cited by 52
Why are clinical trials of glucosamine no longer uniformly positive?
McAlindon, T. E. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00064-4 · Cited by 50
A consumer's guide to finding, evaluating, and reporting on measurement instruments
DeVellis, R. F. (1996) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199606)9:3<170::aid-anr1790090304>3.0.co;2-k · Cited by 38
Published meta-analyses of pharmacological therapies for osteoarthritis
Towheed, T. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0841 · Cited by 37
Self-citationMehta, K., Gala, J., Bhasale, S., Naik, S., Modak, M., Thakur, H. P., Deo, N., & Miller, M. J. S. (2007) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-7-34 · Cited by 36
Glucosamine Use in Pregnancy: An Evaluation of Pregnancy Outcome
Sivojelezova, A., Koren, G., & Einarson, A. (2007) · Journal of Women s Health · doi:10.1089/jwh.2006.0149 · Cited by 8
Acute interstitial nephritis induced by glucosamine
Audimoolam, V. K., & Bhandari, S. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl025 · Cited by 8
Lawrence (1998) · doi:10.1002/1529-0131(199805)41:5<778::aid-art4>3.0.co;2-v
Cited by
OARSI guidelines for the non-surgical management of knee osteoarthritis
McAlindon, T. E., Bannuru, R. R., Sullivan, M. C., Arden, N. K., Berenbaum, F., Bierma-Zeinstra, S. M., Hawker, G. A., Henrotin, Y., Hunter, D. J., Kawaguchi, H., et al. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.01.003 · Cited by 3,110
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Self-citationZhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Self-citationOARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Self-citationZhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Metadata
- Authors
- Towheed, T., Maxwell, L., Anastassiades, T. P., Shea, B., Houpt, J., Welch, V., Hochberg, M. C., & Wells, G. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2005-04-20
- Volume
- 2009
- Issue
- 4
- Pages
- CD002946-CD002946
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2115506640
- Cited by
- 659
- References
- 77
- FWCI
- 30.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.